{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:47:50Z","timestamp":1785797270062,"version":"3.56.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010829","name":"Scientific Research Program of the Higher Education Institution of Xinjiang","doi-asserted-by":"crossref","award":["XJEDU2018I012"],"award-info":[{"award-number":["XJEDU2018I012"]}],"id":[{"id":"10.13039\/501100010829","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s11418-022-01644-z","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T05:02:54Z","timestamp":1660885374000},"page":"41-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of the efficacy of gossypol acetate enantiomers in rats with uterine leiomyoma"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0304-567X","authenticated-orcid":false,"given":"Jie","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"1644_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ibmb.2016.02.005","volume":"71","author":"C Krempl","year":"2016","unstructured":"Krempl C, Sporer T, Reichelt M, Ahn SJ, Heidel-Fischer H, Vogel H, Heckel DG, Jou\u00dfen N (2016) Potential detoxification of gossypol by UDP-glycosyltransferases in the two Heliothine moth species Helicoverpa armigera and Heliothis virescens. Insect Biochem Molec 71:49\u201357","journal-title":"Insect Biochem Molec"},{"key":"1644_CR2","first-page":"33","volume":"22","author":"SL Liu","year":"2002","unstructured":"Liu SL, Kulp SK, Sugimoto Y, Jiang JH, Chang HL, Dowd MK, Wan P, Lin YC (2002) The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer. Anticancer Res 22:33\u201338","journal-title":"Anticancer Res"},{"key":"1644_CR3","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s10753-018-0868-6","volume":"41","author":"CW Chen","year":"2018","unstructured":"Chen CW, Hu S, Tsui KH, Hwang GS, Chen ST, Tang TK, Cheng HT, Yu JW, Wang HC, Juang HH, Wang PS, Wang SW (2018) Anti-inflammatory effects of gossypol on human lymphocytic jurkat cells via regulation of MAPK signaling and cell cycle. Inflammation 41:2265\u20132274","journal-title":"Inflammation"},{"key":"1644_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00011-013-0603-6","volume":"62","author":"ZC Liu","year":"2013","unstructured":"Liu ZC, Yang ZT, Fu YH, Li FY, Liang DJ, Zhou ES, Song XJ, Zhang W, Zhang XC, Cao YG, Zhang NS (2013) Protective effect of gossypol on lipopolysaccharide-induced acute lung injury in mice. Inflamm Res 62:499\u2013506","journal-title":"Inflamm Res"},{"key":"1644_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3109\/08820139.2014.892962","volume":"43","author":"NA Kaushal","year":"2014","unstructured":"Kaushal NA, Kaushal DC (2014) Production and characterization of monoclonal antibodies against substrate specific loop region of Plasmodium falciparum lactate dehydrogenase. Immunol Invest 43:556\u2013571","journal-title":"Immunol Invest"},{"key":"1644_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/v11111019","volume":"11","author":"YN Gao","year":"2019","unstructured":"Gao YN, Tai WB, Wang N, Li X, Jiang SB, Debnath AK, Du LY, Chen SZ (2019) Identification of novel natural products as effective and broad-spectrum anti-zika virus inhibitors. Viruses 11:1019\u20131036","journal-title":"Viruses"},{"key":"1644_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.bmc.2015.08.015","volume":"24","author":"L Li","year":"2016","unstructured":"Li L, Li Z, Wang KL, Liu YX, Li YQ, Wang QM (2016) Synthesis and antiviral, insecticidal, and fungicidal activities of gossypol derivatives containing alkylimine, oxime or hydrazine moiety. Bioorgan Med Chem 24:474\u2013483","journal-title":"Bioorgan Med Chem"},{"key":"1644_CR8","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1016\/j.fct.2010.09.004","volume":"48","author":"AS Ei-Sharaky","year":"2010","unstructured":"Ei-Sharaky AS, Newairy AA, Elguindy NM, Elwafa AA (2010) Spermatotoxicity, biochemical changes and histological alteration induced by gossypol in testicular and hepatic tissues of male rats. Food Chem Toxicol 48:3354\u20133361","journal-title":"Food Chem Toxicol"},{"key":"1644_CR9","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.2147\/DDDT.S256566","volume":"14","author":"YQ Liu","year":"2020","unstructured":"Liu YQ, Ma YL, Li Z, Yang Y, Yu B, Zhang ZY, Wang GY (2020) Investigation of inhibition effect of gossypol-acetic acid on gastric cancer cells based on a network pharmacology approach and experimental validation. Drug Des Dev Ther 14:3615\u20133623","journal-title":"Drug Des Dev Ther"},{"key":"1644_CR10","doi-asserted-by":"publisher","first-page":"116333","DOI":"10.1016\/j.carbpol.2020.116333","volume":"240","author":"N Beyazit","year":"2020","unstructured":"Beyazit N, \u00c7akran HS, Cabir A, Ak\u0131\u015fcan Y, Demetg\u00fcl C (2020) Synthesis, characterization and antioxidant activity of chitosan Schiff base derivatives bearing (-)-gossypol. Carbohyd Polym 240:116333\u2013116341","journal-title":"Carbohyd Polym"},{"key":"1644_CR11","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.2174\/0929867033456369","volume":"10","author":"P Kovacic","year":"2003","unstructured":"Kovacic P (2003) Mechanism of drug and toxic actions of gossypol: focus on reactive oxygen species and electron transfer. Curr Med Chem 10:2711\u20132718","journal-title":"Curr Med Chem"},{"key":"1644_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.aquaculture.2014.02.040","volume":"428","author":"XF Wang","year":"2014","unstructured":"Wang XF, Li XQ, Leng XJ, Shan LL, Zhao JX, Wang YT (2014) Effects of dietary cottonseed meal level on the growth, hematological indices, liver and gonad histology of juvenile common carp (Cyprinus carpio). Aquaculture 428:79\u201387","journal-title":"Aquaculture"},{"key":"1644_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40659-015-0026-7","volume":"48","author":"AT Santana","year":"2015","unstructured":"Santana AT, Guelfi M, Medeiros HCD, Tavares MA, Bizerra PFV (2015) Mechanisms involved in reproductive damage caused by gossypol in rats and protective effects of vitamin E. Biol Res 48:43\u201350","journal-title":"Biol Res"},{"key":"1644_CR14","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1007\/s11010-021-04174-6","volume":"476","author":"M EI Sabeh","year":"2021","unstructured":"EI Sabeh M, Saha SK, Afrin S, Islam MS, Borahay MA (2021) Wnt\/\u03b2-catenin signaling pathway in uterine leiomyoma: role in tumor biology and targeting opportunities. Mol Cell Biochem 476:3513\u20133536","journal-title":"Mol Cell Biochem"},{"key":"1644_CR15","first-page":"22","volume":"7","author":"K Geethamala","year":"2016","unstructured":"Geethamala K, Murthy VS, Vani BR, Rao S (2016) Uterine leiomyomas: an enigma. J Midlife Health 7:22\u201327","journal-title":"J Midlife Health"},{"key":"1644_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1071-55760300004-2","volume":"10","author":"N Chegini","year":"2003","unstructured":"Chegini N, Verala J, Luo X, Xu J, Williams RS (2003) Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Invest 10:161\u2013171","journal-title":"J Soc Gynecol Invest"},{"key":"1644_CR17","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3390\/cancers12082298","volume":"12","author":"DJ Mallick","year":"2020","unstructured":"Mallick DJ, Eastman A (2020) AT101 [(-)-Gossypol] selectively inhibits MCL1 and sensitizes carcinoma to BH3 mimetics by inducing and stabilizing NOXA. Cancers 12:2298\u20132313","journal-title":"Cancers"},{"key":"1644_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0165-1161(86)90043-9","volume":"164","author":"Y Chen","year":"1986","unstructured":"Chen Y, Sten M, Nordenskj\u00f6ld M, Lambert B, Matlin SA, Zhou RH (1986) The effect of gossypol on the frequency of DNA-strand breaks in human leukocytes in vitro. Mutat Res 164:71\u201378","journal-title":"Mutat Res"},{"key":"1644_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.coph.2015.05.014","volume":"23","author":"L Vela","year":"2015","unstructured":"Vela L, Marzo I (2015) Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside. Curr Opin Pharmacol 23:74\u201381","journal-title":"Curr Opin Pharmacol"},{"key":"1644_CR20","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1021\/jm060460o","volume":"49","author":"GP Wang","year":"2006","unstructured":"Wang GP, Nikolovska-Coleska Z, Yang CY, Wang RX, Tang GZ, Guo J, Shangary S, Qiu S, Gao W, Yang DJ, Meagher J, Stuckey J, Krajewski K, Jiang S, Roller PP, Abaan HO, Tomita Y, Wang SM (2006) Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. J Med Chem 49:6139\u20136142","journal-title":"J Med Chem"},{"key":"1644_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bcp.2017.03.006","volume":"136","author":"M Opydo-Chanek","year":"2017","unstructured":"Opydo-Chanek M, Gonzalo O, Marzo I (2017) Multifaceted anticancer activity of BH3 mimetics: current evidence and future prospects. Biochem Pharmacol 136:12\u201323","journal-title":"Biochem Pharmacol"},{"key":"1644_CR22","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/sj.onc.1210220","volume":"26","author":"JM Adams","year":"2007","unstructured":"Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26:1324\u20131337","journal-title":"Oncogene"},{"key":"1644_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3109\/13880209.2013.832776","volume":"52","author":"H Keshmiri-Neghab","year":"2014","unstructured":"Keshmiri-Neghab H, Goliaei B (2014) Therapeutic potential of gossypol: an overview. Pharm Biol 52:124\u2013128","journal-title":"Pharm Biol"},{"key":"1644_CR24","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1097\/JTO.0b013e3181e8f4dc","volume":"5","author":"RS Heist","year":"2010","unstructured":"Heist RS, Fain J, Chinnasami B, Khan W, Molina JR, Sequist LV, Temel JS, Fidias P, Brainerd V, Leopold L, Lynch TJ (2010) Phase I\/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer. J Thorac Oncol 5:1637\u20131643","journal-title":"J Thorac Oncol"},{"key":"1644_CR25","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1097\/JTO.0b013e31822e2941","volume":"6","author":"MQ Baggstrom","year":"2011","unstructured":"Baggstrom MQ, Qi YW, Koczywas M, Argiris A, Johnson EA, Millward MJ, Murphy SC, Erlichman C, Rudin CM, Govindan R (2011) A phase II study of AT-101 (gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer. J Thorac Oncol 6:1757\u20131760","journal-title":"J Thorac Oncol"},{"key":"1644_CR26","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10637-019-00807-2","volume":"38","author":"MN Stein","year":"2019","unstructured":"Stein MN, Goodin S, Gounder M, Gibbon D, Moss R, Portal D, Lindquist D, Zhao Y, Takebe N, Tan A, Aisner J, Lin H, Ready N, Mehnert JM (2019) A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors. Invest New Drug 38:855\u2013865","journal-title":"Invest New Drug"},{"key":"1644_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10637-016-0364-5","volume":"34","author":"PL Swiecicki","year":"2016","unstructured":"Swiecicki PL, Bellile E, Sacco AG, Pearson AT, Taylor JG, Jackson TL, Chepeha DB, Spector ME, Shuman A, Malloy K, Moyer J, McKean E, McLean S, Sukari A, Wolf GT, Eisbruch A, Prince M, Bradford C, Carey TE, Wang SM, N\u00f6r JE, Worden FP (2016) A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer. Invest New Drug 34:481\u2013489","journal-title":"Invest New Drug"},{"key":"1644_CR28","doi-asserted-by":"publisher","first-page":"16043","DOI":"10.1200\/jco.2008.26.15_suppl.16043","volume":"26","author":"GR MacVicar","year":"2008","unstructured":"MacVicar GR, Kuzel TM, Curti BD, Poiesz B, Somer BG, Greco FA, Gressler V, Brill K, Leopold L (2008) An open-label, multicenter, phase I\/II study of AT-101 in combination with docetaxel (D) and prednisone (P) in men with hormone refractory prostate cancer (HRPC). J Clin Oncol 26:16043\u201316043","journal-title":"J Clin Oncol"},{"key":"1644_CR29","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1158\/1078-0432.CCR-08-2985","volume":"15","author":"G Liu","year":"2009","unstructured":"Liu G, Kelly WK, Wilding G, Leopold L, Brill K, Somer B (2009) An open-label, multicenter, phase I\/II study of single-agent AT-101 in men with castrate-resistant prostate cancer. Clin Cancer Res 15:3172\u20133176","journal-title":"Clin Cancer Res"},{"key":"1644_CR30","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/annonc\/mdr555","volume":"23","author":"G Sonpavde","year":"2012","unstructured":"Sonpavde G, Matveev V, Burke JM, Caton JR, Fleming MT, Hutson TE, Galsky MD, Berry WR, Karlov P, Holmlund JT, Wood BA, Brookes M, Leopold L (2012) Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer. Ann Oncol 23:1803\u20131808","journal-title":"Ann Oncol"},{"key":"1644_CR31","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10637-019-00827-y","volume":"38","author":"L Masuelli","year":"2020","unstructured":"Masuelli L, Benvenuto M, Izzi V, Zago E, Mattera R, Cerbelli B, Potenza V, Fazi S, Ciuffa S, Tresoldi I, Lucarelli E, Modesti A, Bei R (2020) In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101. Invest New Drug 38:675\u2013689","journal-title":"Invest New Drug"},{"key":"1644_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00432-019-03107-7","volume":"146","author":"M Mehner","year":"2020","unstructured":"Mehner M, Kubelt C, Adamski V, Schmitt C, Synowitz M, Held-Feindt J (2020) Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells. J Cancer Res Clin Oncol 146:117\u2013126","journal-title":"J Cancer Res Clin Oncol"},{"key":"1644_CR33","first-page":"1732","volume":"34","author":"J Yao","year":"2014","unstructured":"Yao J, Li HF, He XW, Li L, Lu Y (2014) Determination of gossypol isomer in compound acetic acid gossypol tablets by HPLC. Chin J Pharm Anal 34:1732\u20131736","journal-title":"Chin J Pharm Anal"},{"key":"1644_CR34","first-page":"21","volume":"43","author":"MY Zhou","year":"2020","unstructured":"Zhou MY, Gulisitan A, Li Y, Yao J (2020) Preparation and content determination of gossypol acetate optical isomer. J Xinjiang Med Univ 43:21\u201324","journal-title":"J Xinjiang Med Univ"},{"key":"1644_CR35","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.trsl.2013.11.008","volume":"163","author":"N Luo","year":"2014","unstructured":"Luo N, Guan QY, Zheng LH, Qu XY, Dai H, Cheng ZP (2014) Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation. Transl Res 163:232\u2013241","journal-title":"Transl Res"},{"key":"1644_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","volume":"357","author":"EA Stewart","year":"2001","unstructured":"Stewart EA (2001) Uterine fibroids. Lancet 357:293\u2013298","journal-title":"Lancet"},{"key":"1644_CR37","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1021\/cb3006243","volume":"8","author":"M Shan","year":"2013","unstructured":"Shan M, Carlson KE, Bujotzek A, Wellner A, Gust R, Weber M, Katzenellenbogen JA, Haag R (2013) Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor. ACS Chem Biol 8:707\u2013715","journal-title":"ACS Chem Biol"},{"key":"1644_CR38","first-page":"1112","volume":"276","author":"C Benassayag","year":"1999","unstructured":"Benassayag C, Leroy MJ, Rigourd V, Robert B, Honor\u00e9 JC, Mignot TM, Vacher-Lavenu MC, Chapron C, Ferr\u00e9 F (1999) Estrogen receptors (ERalpha\/ERbeta) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma. Am J Physiol 276:1112\u20131118","journal-title":"Am J Physiol"},{"key":"1644_CR39","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1210\/endo.138.11.5496","volume":"138","author":"JF Couse","year":"1997","unstructured":"Couse JF, Lindzey J, Grandien K, Gustafsson J\u00c5, Korach KS (1997) Tissue distribution and quantitative analysis of estrogen receptor-\u03b1 (ER\u03b1) and estrogen receptor-\u03b2 (ER\u03b2) messenger ribonucleic acid in the wild-type and ER\u03b1-knockout mouse. Endocrinology 138:4613\u20134621","journal-title":"Endocrinology"},{"key":"1644_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1210\/er.2012-1043","volume":"34","author":"JJ Kim","year":"2013","unstructured":"Kim JJ, Kurita T, Bulun SE (2013) Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev 34:130\u2013162","journal-title":"Endocr Rev"},{"key":"1644_CR41","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.fertnstert.2003.08.043","volume":"81","author":"K Bodner","year":"2004","unstructured":"Bodner K, Bodner-adler B, Kimberger O, Czerwenka K, Mayerhofer K (2004) Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors. Fertil Steril 81:1062\u20131066","journal-title":"Fertil Steril"},{"key":"1644_CR42","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.fertnstert.2007.09.019","volume":"90","author":"P Bakas","year":"2008","unstructured":"Bakas P, Liapis A, Vlahopoulos S, Giner M, Logotheti S, Creatsas G, Meligova AK, Alexis MN, Zoumpourlis V (2008) Estrogen receptor \u03b1 and \u03b2 in uterine fibroids: a basis for altered estrogen responsiveness. Fertil Steril 90:1878\u20131885","journal-title":"Fertil Steril"},{"key":"1644_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.5468\/ogs.2014.57.2.144","volume":"57","author":"EH Kim","year":"2014","unstructured":"Kim EH, Kim JY, Lee YH, Chong GO, Park JY, Hong DG (2014) Comparison of estrogen receptor-\u03b1, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and-resistant uterine fibroids. Obstet Gynecol Sci 57:144\u2013150","journal-title":"Obstet Gynecol Sci"},{"key":"1644_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20030407","volume":"374","author":"PC Heinrich","year":"2003","unstructured":"Heinrich PC, Behrmann I, Haan S, Hermanns HM, M\u00fcller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1\u201320","journal-title":"Biochem J"},{"key":"1644_CR45","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1096\/fasebj.4.11.2199284","volume":"4","author":"S Akira","year":"1990","unstructured":"Akira S, Hirano T, Taga T, Kishimoto T (1990) Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 4:2860\u20132867","journal-title":"FASEB J"},{"key":"1644_CR46","doi-asserted-by":"publisher","first-page":"668032","DOI":"10.3389\/fcell.2021.668032","volume":"9","author":"M Gagat","year":"2021","unstructured":"Gagat M, Zieli\u0144ska W, Miko\u0142ajczyk K, Zabrzy\u0144ski J, Krajewski A, Klimaszewska-Wi\u015bniewska A, Grzanka D, Grzanka A (2021) CRISPR-based activation of endogenous expression of TPM1 inhibits inflammatory response of primary human coronary artery endothelial and smooth muscle cells induced by recombinant human tumor necrosis factor \u03b1. Front Cell Dev Biol 9:668032\u2013668055","journal-title":"Front Cell Dev Biol"},{"key":"1644_CR47","doi-asserted-by":"publisher","first-page":"103155","DOI":"10.1016\/j.jri.2020.103155","volume":"141","author":"A Borthakur","year":"2020","unstructured":"Borthakur A, Prabhu YD, Gopalakrishnan AV (2020) Role of IL-6 signalling in polycystic ovarian syndrome associated inflammation. J Reprod Immunol 141:103155\u2013103162","journal-title":"J Reprod Immunol"},{"key":"1644_CR48","doi-asserted-by":"publisher","first-page":"736739","DOI":"10.3389\/fvets.2021.736739","volume":"8","author":"LX Liu","year":"2021","unstructured":"Liu LX, Li QQ, Yang YJ, Guo AW (2021) Biological function of short-chain fatty acids and its regulation on intestinal health of poultry. Front Vet Sci 8:736739\u2013736751","journal-title":"Front Vet Sci"},{"key":"1644_CR49","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/biology10100948","volume":"10","author":"H Peng","year":"2021","unstructured":"Peng H, Harvey BT, Richards CI, Nixon K (2021) Neuron-derived extracellular vesicles modulate microglia activation and function. Biology 10:948\u2013960","journal-title":"Biology"},{"key":"1644_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0960-0760(91)90058-D","volume":"39","author":"GW Sang","year":"1991","unstructured":"Sang GW, Lorenzo B, Reidenberg MM (1991) Inhibitory effects of gossypol on corticosteroid 11-beta-hydroxysteroid dehydrogenase from guinea pig kidney: a possible mechanism for causing hypokalemia. J Steroid biochem molec biol 39:169\u2013176","journal-title":"J Steroid biochem molec biol"},{"key":"1644_CR51","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jep.2015.01.004","volume":"162","author":"XX Li","year":"2015","unstructured":"Li XX, Du FY, Liu HX, Ji JB, Xing J (2015) Investigation of the active components in Tripterygium wilfordii leading to its acute hepatotoxicty and nephrotoxicity. J Ethnopharmacol 162:238\u2013243","journal-title":"J Ethnopharmacol"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-022-01644-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-022-01644-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-022-01644-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T01:08:34Z","timestamp":1673140114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-022-01644-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1644"],"URL":"https:\/\/doi.org\/10.1007\/s11418-022-01644-z","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"assertion":[{"value":"12 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}